Mark J C van Treijen

Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study

Arthur J. A. T. Braat, Rutger C. G. Bruijnen, Rob van Rooij et al. · The Lancet Oncology · 2020 · 74 citations

Hepatology, Additional Holmium-166 Radioembolisation, Medicine +13

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study

Mark J C van Treijen, Catharina M. Korse, Rachel S. van Leeuwaarde et al. · Frontiers in Endocrinology · 2018 · 57 citations · Full text

Blood Molecular Genomic Analysis Predicts the Disease Course of Gastroenteropancreatic Neuroendocrine Tumor Patients: A Validation Study of the Predictive Value of the NETest®

Mark J C van Treijen, Dennis van der Zee, Birthe C. Heeres et al. · Neuroendocrinology · 2020 · 32 citations · Full text

Prognosis, Pathology, Predictive Value +21

A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression

Johannes F. Fahrmann, Amanda R. Wasylishen, Carolina R C Pieterman et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 18 citations · Full text

Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group

Mirthe J Klein Haneveld, Mark J C van Treijen, Carolina R C Pieterman et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 14 citations · Full text